PRESS-RELEASE ·Filed Sep 23, 2026
Press release · M&A
Actionable Insight ▲ Bullish
The shareholder vote and HSR clearance remove two key conditions. Monitor for remaining regulatory approvals and the final closing date. The deal is on track for late 2026 or early 2027.
Latest settled — T+20d ⚠ clustered
TECH ▲ +0.17% at T+20d
LONG call ✓ call won +0.17% · α vs SPY -0.52% · entry $72.52 → $72.64
Latest observation: T+22 -1.11% FF3 residual α
T+1d
+0.07%
call +0.07% · α +0.15%
$72.57
settled 5w ago
T+5d
-0.07%
call -0.07% · α +0.61%
$72.47
settled 27d ago
T+20d
+0.17%
call +0.17% · α -0.52%
$72.64
settled 6d ago
T+60d
Pending
in 7w
Price Chart
Loading chart...
Executive Summary
Bio-Techne shareholders voted to approve the acquisition by Merck KGaA, Darmstadt, Germany. The HSR waiting period has expired, and the transaction is expected to close by late 2026 or early 2027, subject to remaining regulatory approvals.
Key Financial Metrics
Revenue
$1.2B
Key Facts
- Shareholders voted to approve the acquisition by Merck KGaA, Darmstadt, Germany at a Special Meeting held on September 23, 2026.
- The Hart-Scott-Rodino waiting period expired on September 18, 2026.
- Transaction expected to close by late 2026 or early 2027, subject to remaining regulatory approvals.
- Bio-Techne generated over $1.2 billion in net sales in fiscal year 2025.
Financial Impact
Acquisition by Merck KGaA, Darmstadt, Germany; deal value not stated in this release.
revenueshare price
Risk Factors
- Remaining regulatory approvals may not be obtained or may impose conditions.
- Transaction could be delayed or terminated if conditions are not satisfied.
- Forward-looking statements subject to risks including integration challenges and market volatility.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302887726 |
6 reports for TECH
75% Hit rate @ T+20 Went positive at some point 4 of 4 best @ T+60▲ +2.07%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 8-K | $72.57 $72.62 | ▲ +0.07% | ▲ +0.49% | $72.60 (+0.04%) |
Sep 23, 2026 4w ago | Press Release | $72.52 $72.64 | ▲ +0.17% | ▼ −0.52% | $72.60 (+0.11%) |
Aug 12, 2026 10w ago | 8-K | $72.23 $72.08 | ▼ −0.21% | ▲ +1.69% | $72.60 (+0.51%) |
Aug 12, 2026 10w ago | Press Release | $72.23 $72.08 | ▼ −0.21% | ▲ +1.69% | $72.60 (+0.51%) |
Aug 10, 2026 11w ago | PREM14A | $72.15 $72.25 | ▲ +0.14% | ▲ +1.20% | $72.60 (+0.62%) |
Jun 25, 2026 17w ago | DEFA14A | $71.00 $71.77 | ▲ +1.08% | ▼ −0.18% | $72.60 (+2.25%) |
Showing 6 of 6
US Market Status
Market Closed — Opens Wed (15h 45m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers